In many cases, trigeminal neuralgia is caused by compression of the facial nerve most commonly by the superior cerebellar artery or the anterior inferior cerebellar artery, although trigeminal neuralgia can be due to compression by a persistent permanent trigeminal artery or odioectatic basilar artery. Other causes of Trigeminal Neuralgia can include demyelinating disease (such as multiple sclerosis) and tumor. In some cases, the cause of Trigeminal Neuralgia is ...
In an upcoming event, Dr. Ryder Gwinn will explain the causes, diagnosis, research and treatment options for essential tremor.
Date: Saturday, January 25
Time: Check-in 9:30am/Program 10am-Noon
Location: Bellevue Hilton, 300 112 Ave SE, Bellevue, WA
There is no charge for the event but please note, parking in the Bellevue Hilton lot is $5.
Registration is required - call 888-387-3667 or visit www.essentialtremor.org/seminars
On November 14th, 2013 the FDA gave its approval for an implanted brain stimulator to treat patients with medically refractory epilepsy. Epilepsy is one of the most common neurological disorders affecting nearly 1 in 100 Americans. This device has been under investigation for 10 years at the Swedish Neuroscience Institute (SNI) Epilepsy Center.
As principal investigator for the trial, I led a team including Dr. Michael Doherty, Dr. Lisa Caylor and Dr. Alan Haltiner, along with the research department at Swedish to investigate the safety and effectiveness of the device through pivotal trials. The results showed that the responsive neurostimulator system (RNS) made by NeuroPace was indeed effective in treating patients with drug resistant seizures.
Why is this so significant? This device represents the first new non-medication treatment for seizures proven to be effective since 1997, and gives new hope to patients whose lives have been put on hold due to seizures. ...
September is National Brain Aneurysm Awareness Month and across the country, those affected by various forms of the disease raise awareness through fundraising and visibility events. Bringing a voice to the disease may seem daunting in a sea of awareness ribbons and weekend community walks—but Swedish had the opportunity to focus a spotlight on Seattle as host for the Brain Aneurysm Foundation’s Annual Symposium. This Massachusetts-based organization is the nation’s only not-for-profit profit organization solely dedicated to providing critical awareness, education, support and research funding to reduce the incidence of brain aneurysms. Swedish Neuroscience Institute physicians teamed up with other elite physicians from across the country and others in the medical community, in addition to volunteers and Brain Aneurysm Foundation members to learn more about advances in research for the disease.
One unique component to this important event was the attendance of members of the Swedish Cerebrovascular Support Group. The group, established in 2012, brings together patients, family members and caregivers to share their experiences, with the goal of alleviating fears and concerns through education and group discussions...
Twice last week I received phone calls from grateful family members thanking us for taking care of their loved ones when treatment options were dwindling. One patient is now 4 years past his CyberKnife treatment for inoperable lung cancer and is going strong and living life to the fullest. The other patient was recently treated and is feeling great and planning a European vacation. Both families are extremely appreciative for the care they received but both voiced frustration that they stumbled upon this treatment option by chance and that we need to do a better job of publicizing the radiosurgery modalities. As the person receiving these calls, I am thrilled to hear how our center has positively impacted so many lives but struggle with how to get the word out to those who may benefit from radiosurgery in the future. So with our patients’ stories fresh in my mind, here is an introduction to radiosurgery.
Stereotactic radiosurgery is targeted radiation therapy delivered to nearly any body part with precision while utilizing real time image guidance. The ....
The treatment of neurologic disease took a major step forward this past week with the publication of a clinical trial that used ultrasound waves to treat Essential Tremor. Essential tremor affects about 10 million people in the USA and can be extremely disabling. For patients that fail medical therapy invasive surgical options are considered, including deep brain stimulation (DBS). DBS surgeries involve drilling a hole in the skull and implanting an electrode into structures deep in the brain to turn off the unwanted signals that cause the tremor.
A study of 15 patients lead by Dr. Jeff Elias (University of Virginia) was published in the New England Journal of Medicine this week and describes how researchers used ultrasound waves to effectively treat Essential tremor non-invasively – no cutting or drilling: